Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMind Gym Plc Regulatory News (MIND)

Share Price Information for Mind Gym Plc (MIND)

Share Price is delayed by 15 minutes
Get Live Data
9.50    0.00 (0.00%)
Bid:
9.00
Ask:
10.00
Spread: 1.00 (11.111%)
Market Cap: £9.53m
MIND Live PriceLast checked at - London Stock Exchange

Intraday Mind Gym Plc Share Chart

Form 8 (Opening Position Disclosure)

4 Feb 2026 11:32

RNS Number : 7251R
Mind Gym PLC
04 February 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MindGym plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MindGym plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

03 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

0.001p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

N/A

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Beneficial holdings of the Directors of MindGym plc (including their close relatives) in its ordinary shares of no par value each 

Name

Number of ordinary shares held

% of voting share capital

Octavius Blanc and Joanne Cash

55 712 055

55.48

Sebastian Bailey

10 341 373

10.30

Emily Fyffe

685

0.07

 

 

(b) Beneficial holdings of the directors of MindGym plc in rights to subscribe for shares in MindGym plc

 

Options over ordinary shares in MindGym plc:

 

Name

Plan

Grant date

Vesting date

Expiry date

Exercise price

No of options/ shares

Emily Fyffe

LTIP1

21 July 2022

21 July 2025

21 July 2032

0

22,916

Emily Fyffe

LTIP2

26 July 2023

26 July 2026

26 July 2033

0

16,616

Emily Fyffe

LTIP3

26 July 2023

26 July 2026

26 July 2033

0

38,770

Christoffer Ellehuus

LTIP2

28 August 2024

28 August 2027

28 August 2034

0

263,158

Emily Fyffe

LTIP2

28 August 2024

28 August 2027

28 August 2034

0

51,810

Christoffer Ellehuus

LTIP3

28 August 2024

28 August 2027

28 August 2034

0

614,035

Emily Fyffe

LTIP3

28 August 2024

28 August 2027

28 August 2034

0

120,889

Christoffer Ellehuus

LTIP1

28 August 2024

28 August 2027

28 August 2034

0

877,193

Emily Fyffe

LTIP1

28 August 2024

28 August 2027

28 August 2034

0

172,699

Christoffer Ellehuus

LTIP3

31 July 2025

31 July 2028

31 July 2035

0

857,143

Emily Fyffe

LTIP3

31 July 2025

31 July 2028

31 July 2035

0

471,429

Christoffer Ellehuus

LTIP2

31 July 2025

31 July 2028

31 July 2035

0

428,571

Emily Fyffe

LTIP2

31 July 2025

31 July 2028

31 July 2035

0

235,714

Christoffer Ellehuus

LTIP1

31 July 2025

31 July 2028

31 July 2035

0

428,571

Emily Fyffe

LTIP1

31 July 2025

31 July 2028

31 July 2035

0

235,714

(1) Timebound LTIP Performance Condition

(2) EBITDA Target LTIP Performance Condition

(3) Revenue Target LTIP Performance Condition

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

04 February 2026

Contact name:

Nicholas Stone

Telephone number:

+44 20 7376 0626

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEETIMBTMTTMBMF
Date   Source Headline
26th Sep 20257:00 amRNSInterim CFO Appointment
17th Sep 20252:48 pmRNSResult of AGM
1st Aug 20257:01 amRNSIssue of ordinary shares and total voting rights
1st Aug 20257:00 amRNSGrant of awards under the Long Term Incentive Plan
14th Jul 20254:15 pmRNSGrant of Options
9th Jul 20252:15 pmRNSAdjournment of AGM
12th Jun 20257:00 amRNSFinal results for the year ended 31 March 2025
31st Mar 20257:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20257:00 amRNS-RSenior Appointment
3rd Dec 20247:00 amRNSHalf Year Results
22nd Oct 20247:01 amRNSCFO succession and Board change
22nd Oct 20247:00 amRNSHalf Year Trading Update & Notice of Results
18th Sep 20247:00 amRNSIssue of ordinary shares and total voting rights
29th Aug 20247:00 amRNSGrant of awards under the Long Term Incentive Plan
28th Aug 20247:00 amRNSCFO succession
18th Jul 20247:00 amRNSGrant of SAYE options
15th Jul 202411:06 amRNSResults of 2024 Annual General Meeting
1st Jul 20247:00 amRNSNominated Adviser and Broker
24th Jun 20243:55 pmRNSNotice of AGM
17th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
29th May 20247:00 amRNSNotice of Results
22nd Apr 20247:01 amRNSDirectorate Changes
22nd Apr 20247:00 amRNSFull Year Trading Update
1st Dec 20237:01 amRNSHalf Year Results
1st Dec 20237:01 amRNSDirectorate Changes
9th Oct 20237:00 amRNSHalf Year Trading Update & Notice of Results
22nd Sep 20233:30 pmRNSGrant of SAYE options
15th Aug 20232:18 pmRNSIssue of Equity
27th Jul 20237:00 amRNSGrant of Awards under the Long Term Incentive Plan
24th Jul 20237:00 amRNSDirector and PDMR Dealing
19th Jul 20235:36 pmRNSResults of 2023 Annual General Meeting
28th Jun 202311:34 amRNSNotice of AGM
15th Jun 20237:00 amRNSNotice of Investor Presentation
13th Jun 20237:00 amRNSFull Year Results
10th May 20237:00 amRNSNotice of Results – Change of Date
24th Apr 20237:00 amRNSFull Year Trading Update
20th Mar 20237:00 amRNSGrant of award under the Long Term Incentive Plan
15th Dec 202211:26 amRNSDirector/PDMR Shareholding
13th Dec 20229:39 amRNSInvestor Presentation
2nd Dec 20227:00 amRNSHalf Year Results
18th Oct 20227:00 amRNSHalf Year Trading Update
16th Aug 20225:37 pmRNSIssue of Shares
15th Aug 20224:11 pmRNSIssue of Shares
18th Jul 20229:03 amRNSGrant of SAYE Options
14th Jul 20222:15 pmRNSResult of AGM
21st Jun 20229:51 amRNSPublication of Annual Report and Notice of AGM
10th Jun 20227:00 amRNSFull Year Results
27th May 202211:00 amRNSNotice of Full Year Results
25th Apr 20227:00 amRNSFull Year Trading Update
27th Jan 20223:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.